SAI
AGIO icon

Savvy Advisors Inc’s Agios Pharmaceuticals AGIO Stock Holding History

Savvy Advisors Inc’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Hold
6,794
– – 0.01% 1074
2026
Q1 		$230K Buy
+6,794
New +$193K 0.01% 993
2025
Q4 		– Sell
-11,993
Closed -$481K – 1032
2025
Q3 		$481K Sell
11,993
-9,788
-45% -$368K 0.02% 437
2025
Q2 		$724K Buy
+21,781
New +$660K 0.05% 277

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Savvy Advisors Inc's AGIO Position: Q2 2026 in Review

Savvy Advisors Inc held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 6,794 shares worth $252K. The position accounts for 0.01% of the portfolio, ranked #1074.

Savvy Advisors Inc first reported a position in AGIO in Q2 2025 and has held it in 4 quarters since. The position peaked at $724K in Q2 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Savvy Advisors Inc held 6,794 shares of Agios Pharmaceuticals worth $252K as of Q2 2026.
  • Savvy Advisors Inc left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up 0.01% of Savvy Advisors Inc's portfolio in Q2 2026, its #1074 holding.
  • Savvy Advisors Inc first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Savvy Advisors Inc's Agios Pharmaceuticals position peaked at $724K in Q2 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.